Forskning ved Københavns Universitet - Københavns Universitet

Forside

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Sten Peder Andersen
  • Harald Mischak
  • Petra Zürbig
  • Hans-Henrik Parving
  • Peter Rossing
Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients. The purpose of this study was to evaluate the effect of treatment with Irbesartan in type 2 diabetic patients with microalbuminuria on the urinary proteome.
OriginalsprogEngelsk
TidsskriftB M C Nephrology
Vol/bind11
Sider (fra-til)29
ISSN1471-2369
DOI
StatusUdgivet - 1 jan. 2010

ID: 34163404